These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 17577119)

  • 1. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C.
    Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Aoki J; Hama K; Okudaira S; Tanaka M; Tomiya T; Yanase M; Tejima K; Nishikawa T; Arai M; Arai H; Omata M; Fujiwara K; Yatomi Y
    J Clin Gastroenterol; 2007 Jul; 41(6):616-23. PubMed ID: 17577119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical introduction of lysophosphatidic acid and autotaxin assays].
    Yatomi Y
    Rinsho Byori; 2010 Jun; 58(6):631-5. PubMed ID: 20662276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity.
    Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Tomiya T; Tejima K; Nishikawa T; Arai M; Yanase M; Aoki J; Arai H; Omata M; Fujiwara K; Yatomi Y
    Life Sci; 2007 Sep; 81(12):1009-15. PubMed ID: 17850827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autotaxin as a novel serum marker of liver fibrosis.
    Nakagawa H; Ikeda H; Nakamura K; Ohkawa R; Masuzaki R; Tateishi R; Yoshida H; Watanabe N; Tejima K; Kume Y; Iwai T; Suzuki A; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Omata M; Igarashi K; Aoki J; Koike K; Yatomi Y
    Clin Chim Acta; 2011 Jun; 412(13-14):1201-6. PubMed ID: 21419756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of serum autotaxin activity in gastrointestinal disease].
    Ikeda H; Watanabe N; Nakamura K; Kume Y; Nakai Y; Fujishiro M; Omata M; Igarashi K; Yokota H; Yatomi Y
    Rinsho Byori; 2009 May; 57(5):445-9. PubMed ID: 19522250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma.
    Masuda A; Nakamura K; Izutsu K; Igarashi K; Ohkawa R; Jona M; Higashi K; Yokota H; Okudaira S; Kishimoto T; Watanabe T; Koike Y; Ikeda H; Kozai Y; Kurokawa M; Aoki J; Yatomi Y
    Br J Haematol; 2008 Oct; 143(1):60-70. PubMed ID: 18710386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lysophospholipase D/autotaxin may be a new nutritional assessment marker: study on prostate cancer patients.
    Nakamura K; Takeuchi T; Ohkawa R; Okubo S; Yokota H; Tozuka M; Aoki J; Arai H; Ikeda H; Ohshima N; Kitamura T; Yatomi Y
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):549-56. PubMed ID: 17961310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autotaxin in liver fibrosis.
    Ikeda H; Yatomi Y
    Clin Chim Acta; 2012 Nov; 413(23-24):1817-21. PubMed ID: 22820036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation.
    Gierse J; Thorarensen A; Beltey K; Bradshaw-Pierce E; Cortes-Burgos L; Hall T; Johnston A; Murphy M; Nemirovskiy O; Ogawa S; Pegg L; Pelc M; Prinsen M; Schnute M; Wendling J; Wene S; Weinberg R; Wittwer A; Zweifel B; Masferrer J
    J Pharmacol Exp Ther; 2010 Jul; 334(1):310-7. PubMed ID: 20392816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid is a potential mediator of cholestatic pruritus.
    Kremer AE; Martens JJ; Kulik W; Ruëff F; Kuiper EM; van Buuren HR; van Erpecum KJ; Kondrackiene J; Prieto J; Rust C; Geenes VL; Williamson C; Moolenaar WH; Beuers U; Oude Elferink RP
    Gastroenterology; 2010 Sep; 139(3):1008-18, 1018.e1. PubMed ID: 20546739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis.
    Pamuklar Z; Federico L; Liu S; Umezu-Goto M; Dong A; Panchatcharam M; Fulkerson Z; Berdyshev E; Natarajan V; Fang X; van Meeteren LA; Moolenaar WH; Mills GB; Morris AJ; Smyth SS
    J Biol Chem; 2009 Mar; 284(11):7385-94. PubMed ID: 19139100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation and biological activities of the autotaxin-LPA axis.
    van Meeteren LA; Moolenaar WH
    Prog Lipid Res; 2007 Mar; 46(2):145-60. PubMed ID: 17459484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of autotaxin, an ectoenzyme that produces lysophosphatidic acid, in human placenta.
    Iwasawa Y; Fujii T; Nagamatsu T; Kawana K; Okudaira S; Miura S; Matsumoto J; Tomio A; Hyodo H; Yamashita T; Oda K; Kozuma S; Aoki J; Yatomi Y; Taketani Y
    Am J Reprod Immunol; 2009 Aug; 62(2):90-5. PubMed ID: 19614625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidylmethanol is a pan lysophosphatidic acid receptor agonist and is produced by autotaxin in blood.
    Endo T; Kano K; Motoki R; Hama K; Okudaira S; Ishida M; Ogiso H; Tanaka M; Matsuki N; Taguchi R; Kanai M; Shibasaki M; Arai H; Aoki J
    J Biochem; 2009 Aug; 146(2):283-93. PubMed ID: 19416959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of lysophospholipase D/autotaxin activity in human serum samples.
    Nakamura K; Ohkawa R; Okubo S; Tozuka M; Okada M; Aoki S; Aoki J; Arai H; Ikeda H; Yatomi Y
    Clin Biochem; 2007 Feb; 40(3-4):274-7. PubMed ID: 17222397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation.
    Nakamura K; Igarashi K; Ide K; Ohkawa R; Okubo S; Yokota H; Masuda A; Oshima N; Takeuchi T; Nangaku M; Okudaira S; Arai H; Ikeda H; Aoki J; Yatomi Y
    Clin Chim Acta; 2008 Feb; 388(1-2):51-8. PubMed ID: 17963703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development.
    van Meeteren LA; Ruurs P; Stortelers C; Bouwman P; van Rooijen MA; Pradère JP; Pettit TR; Wakelam MJ; Saulnier-Blache JS; Mummery CL; Moolenaar WH; Jonkers J
    Mol Cell Biol; 2006 Jul; 26(13):5015-22. PubMed ID: 16782887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular mechanism of cholestatic pruritus.
    Oude Elferink RP; Kremer AE; Martens JJ; Beuers UH
    Dig Dis; 2011; 29(1):66-71. PubMed ID: 21691108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATX expression and LPA signalling are vital for the development of the nervous system.
    Fotopoulou S; Oikonomou N; Grigorieva E; Nikitopoulou I; Paparountas T; Thanassopoulou A; Zhao Z; Xu Y; Kontoyiannis DL; Remboutsika E; Aidinis V
    Dev Biol; 2010 Mar; 339(2):451-64. PubMed ID: 20079728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate.
    Song J; Clair T; Noh JH; Eun JW; Ryu SY; Lee SN; Ahn YM; Kim SY; Lee SH; Park WS; Yoo NJ; Lee JY; Nam SW
    Biochem Biophys Res Commun; 2005 Nov; 337(3):967-75. PubMed ID: 16219296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.